Ephraim Chikwanda holds a Master of Science in Pathology (Haematology) and a Bachelor of Science in Biomedical Sciences, obtained from the University of Zambia. He has more than 7 years' of laboratory experience in the areas of microbiology, serology, hematology, immunology, molecular biology and clinical chemistry. Currently, he is a Laboratory Manager at Zambia Emory HIV Research Project (ZEHRP), Ndola, Zambia. He is involved in a Simulated Vaccine Efficacy Trials (SiVET) using MMR and Tdap-IPV in Healthy, HIV negative women at high risk of HIV infection in Ndola, Zambia, and a collaborative project focusing on Intravaginal Practices (IVP) in female sex workers and single mothers in the Copperbelt. He has worked on a Protocol C Study, which focuses on the natural history and predictors of incidence of HIV, with a particular emphasis on the population of HIV discordant couples to investigate the behavioural, clinical, virologic, immunologic, and immunogenetic correlates of heterosexual transmission of HIV. He has also worked on NIH Protocol 1 focusing on the impact of CVCT on HIV transmission in Discordant Couples that were identified in Copperbelt and Lusaka Provinces. His main area of interest is Acute HIV infection (AHI) and multidrug-resistance tuberculosis (MDR-TB) in multiple risk groups.